LetterLetter
Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study
Katherine Majerovich, Mats Junek, Nader Khalidi and Stephanie Garner
The Journal of Rheumatology January 2023, jrheum.220860; DOI: https://doi.org/10.3899/jrheum.220860
Katherine Majerovich
University College Dublin School of Medicine, Belfield, Dublin, Ireland. Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Division of Rheumatology, Department of Medicine, St. Joseph's Healthcare, and McMaster University, Hamilton, Ontario, Canada. NK has received consulting fees from BMS, Sanofi, and AbbVie clinical trials, and an AstraZeneca travel grant; and was a member of the Roche advisory board (2020). The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to K. Majerovich, Apartment 4, 88 Sandymount Road, Dublin, D04 K076, Ireland. Email: Katherine.majerovich@ucdconnect.ie.
Mats Junek
University College Dublin School of Medicine, Belfield, Dublin, Ireland. Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Division of Rheumatology, Department of Medicine, St. Joseph's Healthcare, and McMaster University, Hamilton, Ontario, Canada. NK has received consulting fees from BMS, Sanofi, and AbbVie clinical trials, and an AstraZeneca travel grant; and was a member of the Roche advisory board (2020). The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to K. Majerovich, Apartment 4, 88 Sandymount Road, Dublin, D04 K076, Ireland. Email: Katherine.majerovich@ucdconnect.ie.
Nader Khalidi
University College Dublin School of Medicine, Belfield, Dublin, Ireland. Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Division of Rheumatology, Department of Medicine, St. Joseph's Healthcare, and McMaster University, Hamilton, Ontario, Canada. NK has received consulting fees from BMS, Sanofi, and AbbVie clinical trials, and an AstraZeneca travel grant; and was a member of the Roche advisory board (2020). The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to K. Majerovich, Apartment 4, 88 Sandymount Road, Dublin, D04 K076, Ireland. Email: Katherine.majerovich@ucdconnect.ie.
Stephanie Garner
University College Dublin School of Medicine, Belfield, Dublin, Ireland. Division of Rheumatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Division of Rheumatology, Department of Medicine, St. Joseph's Healthcare, and McMaster University, Hamilton, Ontario, Canada. NK has received consulting fees from BMS, Sanofi, and AbbVie clinical trials, and an AstraZeneca travel grant; and was a member of the Roche advisory board (2020). The remaining authors declare no conflicts of interest relevant to this article. Address correspondence to K. Majerovich, Apartment 4, 88 Sandymount Road, Dublin, D04 K076, Ireland. Email: Katherine.majerovich@ucdconnect.ie.
Abstract
Giant cell arteritis (GCA) is the most common large-vessel vasculitis that primarily affects older individuals.1 Prompt diagnosis and treatment with empiric glucocorticoids (GCs) is important because GCA can lead to ischemic complications, including visual loss.1,2
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Duration of Steroid Therapy and Temporal Artery Biopsy Positivity in Giant Cell Arteritis: A Retrospective Cohort Study
Katherine Majerovich, Mats Junek, Nader Khalidi, Stephanie Garner
The Journal of Rheumatology Jan 2023, jrheum.220860; DOI: 10.3899/jrheum.220860